Combination therapy improves survival outcomes for patients with acute myeloid leukemia

HOUSTON – A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center. The results were presented in the virtual 25th European Hematology Association…

Trump’s Order on Coronavirus Relief Alarms Governors as Stimulus Talks Stall

This briefing has ended. Read live coronavirus updates here. Here’s what you need to know: ImagePresident Trump at his coronavirus news conference on Monday. Governors across the country on Monday struggled to figure out how to deliver billions more in unemployment benefits to jobless residents.Credit…Doug Mills/The New York Times Governors say Trump’s order on pandemic…